Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativit
- Research Organization:
- Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)
- Sponsoring Organization:
- DOE - Office Of Science; NIH
- OSTI ID:
- 1855444
- Journal Information:
- J. Med. Chem., Journal Name: J. Med. Chem. Journal Issue: (4) Vol. 65
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativit
Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativit
An oral SARS-CoV-2 M[superscript pro] inhibitor clinical candidate for the treatment of COVID-19
Journal Article
·
2022
· J. Med. Chem.
·
OSTI ID:1856408
Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativit
Journal Article
·
2022
· J. Med. Chem.
·
OSTI ID:1861875
An oral SARS-CoV-2 M[superscript pro] inhibitor clinical candidate for the treatment of COVID-19
Journal Article
·
2021
· Science
·
OSTI ID:1844723